Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000539101 | SCV000641652 | likely benign | Tuberous sclerosis 1 | 2023-08-08 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000832612 | SCV000974368 | likely benign | not provided | 2019-08-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000539101 | SCV002040512 | benign | Tuberous sclerosis 1 | 2021-11-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002367855 | SCV002625908 | likely benign | Hereditary cancer-predisposing syndrome | 2023-09-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV004689787 | SCV005184636 | likely benign | not specified | 2024-05-24 | criteria provided, single submitter | clinical testing |